Abdulmohsen H Al-Elq1. 1. Department of Internal Medicine, College of Medicine, King Faisal University, Dammam, and King Fahd University Hospital, PO Box 40145, Al-Khobar 31952, Kingdom of Saudi Arabia. aalelq@yahoo.com
Abstract
OBJECTIVE: To gather data on current practices in the management of patients with type 2 diabetes mellitus (T2DM) in Saudi Arabia and to evaluate the degree of compliance with international guidelines. METHODS: This paper represents the results of the Saudi Arabia T2DM data collected at the cross-sectional part of Wave 2006 of the International Diabetes Management Practices Study (IDMPS). Data were collected on a case report form from 28 health centers all over the Kingdom of Saudi Arabia, in the period between 01/12/2006 and 30/12/2006. It included demographic and socioeconomic profile in addition to diabetes management and metabolic control. RESULTS: Three hundred and fifty-three Saudi T2DM diabetic patients were studied. The mean age was 51.61+/-10.84 years; average duration of diabetes was 8.25+/-6.49 years; 63-86% had never been screened for diabetes complications or cardiovascular risk factors during the previous year. Of all patients with T2DM, 7% were treated with insulin alone, 28% with oral glucose lowering drug (OGLD) + insulin and 64% with OGLD alone. The average last hemoglobin A1c (HbA1c) was 8.20+/-1.89% and among all patients, only 27% had reached the target HbA1c of <7% while 42% of patients had been considered as reached glycemic control by physicians. Sixteen percent attained the target blood pressure of <130/80, and 65% had lipid profile above the optimal level. CONCLUSION: The majority of patients did not attain the recommended target glycemic level. This indicates the presence of a gap between recommendations of the international guidelines and the actual practices.
OBJECTIVE: To gather data on current practices in the management of patients with type 2 diabetes mellitus (T2DM) in Saudi Arabia and to evaluate the degree of compliance with international guidelines. METHODS: This paper represents the results of the Saudi Arabia T2DM data collected at the cross-sectional part of Wave 2006 of the International Diabetes Management Practices Study (IDMPS). Data were collected on a case report form from 28 health centers all over the Kingdom of Saudi Arabia, in the period between 01/12/2006 and 30/12/2006. It included demographic and socioeconomic profile in addition to diabetes management and metabolic control. RESULTS: Three hundred and fifty-three Saudi T2DM diabeticpatients were studied. The mean age was 51.61+/-10.84 years; average duration of diabetes was 8.25+/-6.49 years; 63-86% had never been screened for diabetes complications or cardiovascular risk factors during the previous year. Of all patients with T2DM, 7% were treated with insulin alone, 28% with oral glucose lowering drug (OGLD) + insulin and 64% with OGLD alone. The average last hemoglobin A1c (HbA1c) was 8.20+/-1.89% and among all patients, only 27% had reached the target HbA1c of <7% while 42% of patients had been considered as reached glycemic control by physicians. Sixteen percent attained the target blood pressure of <130/80, and 65% had lipid profile above the optimal level. CONCLUSION: The majority of patients did not attain the recommended target glycemic level. This indicates the presence of a gap between recommendations of the international guidelines and the actual practices.
Authors: Khalid F Alhabib; Ahmad Hersi; Hussam Alfaleh; Khalid Alnemer; Shukri Alsaif; Amir Taraben; Tarek Kashour; Anas Bakheet; Ayed Al Qarni; Tariq Soomro; Asif Malik; Waqar H Ahmed; Ahmed M Abuosa; Modaser A Butt; Mushabab A Almurayeh; Abdulaziz Al Zaidi; Gamal A Hussein; Mohammed A Balghith; Tareg Abu-Ghazala Journal: J Saudi Heart Assoc Date: 2011-06-01